Our News

CN Bio and Imperial College London Collaboration

CN Bio and Imperial College London collaborate to identify novel treatments for alcoholic hepatitis. CN Bio’s Liver-on-Chip technology to define underlying disease mechanisms and screen therapeutic targets. CN Bio, a leading cell culture company, that has developed...

read more

NASH Drug Discovery Service Launched at AASLD

Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis (NASH) therapeutics. CN Bio launched the program at the American Association for the Study of Liver...

read more

CN Bio to bring 10 organs together on a chip

London Organ-­on-­Chip specialist CN Bio today announced it has secured an exclusive license to technology from the Massachusetts Institute of Technology for Organ-­on-­Chip systems which connect human tissues from up to 10 organs. CN Bio participated with MIT on a...

read more
About CN Bio

CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.

As an EOE employer, CN Bio will not discriminate in its employment practices due to an applicant’s race, color, religion, sex, national origin, sexual orientation, gender identity, disability or veteran status.